The polypill: the solution for prevention of coronary heart disease?
Main Article Content
Abstract
Article Details
Issue
Section
The journal allows the authors to hold the copyright without restrictions and allow the authors to retain publishing rights without restrictions.
How to Cite
References
Ezzati M, Hoorn SV, Rodgers A, Lopez AD, Mathers CD, Murray CJ. Estimates of global and regional potential health gains from reducing multiple major risk factors. Lancet 2003:362:271-80.
Panchin N, Cambon JP, Hanama G, Kadri Z, Genes N, Cablanche JM, et al. USIC 2000 Investigators. Impact of combined secondary prevention therapy after acute myocardial infarction: data from a nationwide French registry. Am Heart J 2005;150:1147-53.
Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMJ 2003;326:1419.
Sleight P, Pouleur H, Zannad F. Benefits, challenges, and registerability of the polypill. European Heart Journal 2006;27:1651–6.